InvestorsHub Logo
Post# of 252300
Next 10
Followers 1
Posts 420
Boards Moderated 0
Alias Born 01/17/2006

Re: None

Wednesday, 03/08/2006 11:26:12 AM

Wednesday, March 08, 2006 11:26:12 AM

Post# of 252300
CNBC covering fda panel decision now

but only muddying waters by presenting only Levin's take on issue of "patient rights, harmful drugs". He's been strongly against bringing tysabri back to mkt. Total BS

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.